CN101360999B - 眼内压调节早期基因及其用途 - Google Patents
眼内压调节早期基因及其用途 Download PDFInfo
- Publication number
- CN101360999B CN101360999B CN2006800515976A CN200680051597A CN101360999B CN 101360999 B CN101360999 B CN 101360999B CN 2006800515976 A CN2006800515976 A CN 2006800515976A CN 200680051597 A CN200680051597 A CN 200680051597A CN 101360999 B CN101360999 B CN 101360999B
- Authority
- CN
- China
- Prior art keywords
- expression
- ipreg
- macroglobulin
- rgc
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/16—Ophthalmology
- G01N2800/168—Glaucoma
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Ophthalmology & Optometry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73957005P | 2005-11-22 | 2005-11-22 | |
| US60/739,570 | 2005-11-22 | ||
| PCT/US2006/045169 WO2007062101A2 (en) | 2005-11-22 | 2006-11-22 | Intraocular pressure-regulated early genes and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101360999A CN101360999A (zh) | 2009-02-04 |
| CN101360999B true CN101360999B (zh) | 2013-07-17 |
Family
ID=38067890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2006800515976A Expired - Fee Related CN101360999B (zh) | 2005-11-22 | 2006-11-22 | 眼内压调节早期基因及其用途 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8563520B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1957986B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5249774B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101360999B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006318550A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2630668C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007062101A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0634001Y2 (ja) | 1989-02-02 | 1994-09-07 | 石川島播磨重工業株式会社 | 水平対向型幅プレスの金型取付装置 |
| AU2006318550A1 (en) * | 2005-11-22 | 2007-05-31 | Mcgill University | Intraocular pressure-regulated early genes and uses thereof |
| US8648169B2 (en) | 2006-12-05 | 2014-02-11 | The Royal Institution For The Advancement Of Learning/Mcgill University | Methods of use of Trk receptor modulators |
| WO2010118340A1 (en) * | 2009-04-09 | 2010-10-14 | University Of Medicine And Dentistry Of New Jersey | Treatment of cutaneous hemangioma |
| CN102210851A (zh) * | 2011-05-31 | 2011-10-12 | 中国人民解放军第三军医大学第一附属医院 | 人αB-晶体蛋白在制备保护视网膜神经节细胞的药物中的应用 |
| US20140228299A1 (en) * | 2011-09-20 | 2014-08-14 | National University Corporation Tokyo Medical And Dental University | Prophylactic and therapeutic agent for neurological diseases using lipoproteins and prophylactic and therapeutic method for neurological diseases |
| EP3140422A1 (en) * | 2014-05-03 | 2017-03-15 | The Regents of The University of California | Methods of identifying biomarkers associated with or causative of the progression of disease, in particular for use in prognosticating primary open angle glaucoma |
| US20180021404A1 (en) * | 2015-02-20 | 2018-01-25 | The Regents Of The University Of California | Methods and compositions for treating glaucoma |
| JP7033840B2 (ja) * | 2016-06-17 | 2022-03-11 | ユーロイミューン・メディツィニシェ・ラボルディアグノシュティカ・アクチエンゲゼルシャフト | 神経自己免疫疾患の診断 |
| CN106434933A (zh) * | 2016-10-11 | 2017-02-22 | 青岛大学 | Crybb2基因在制备检测先天性白内障制品中的应用 |
| US12606868B2 (en) | 2020-02-24 | 2026-04-21 | The Board Of Regents Of The University Of Texas System | Molecular biomarkers and targets for Fuchs' endothelial corneal dystrophy and glaucoma |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2237430Y (zh) * | 1995-07-20 | 1996-10-16 | 北京市橡胶制品设计研究院 | 青光眼房水引流盘 |
| WO2004069258A2 (de) * | 2003-02-07 | 2004-08-19 | Florian Lang | Verwendung der sgk-genfamilie zur diagnose und zur therapie von katarakt und glaukom |
| WO2005060542A2 (en) * | 2003-12-17 | 2005-07-07 | Alcon, Inc. | Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) * | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| US6441047B2 (en) * | 1995-11-17 | 2002-08-27 | Alcon Manufacturing Ltd.. | Combination therapy for treating glaucoma |
| US6482854B1 (en) * | 1999-03-25 | 2002-11-19 | Massachusetts Eye And Ear Infirmary | Glaucoma treatment |
| DE602005012812D1 (de) * | 2005-06-13 | 2009-04-02 | Primm Srl | Heterodimere Peptide mit NGF Aktivität und deren Verwendung zur Behandlung von neurodegenerativen Krankheiten |
| AU2006318550A1 (en) * | 2005-11-22 | 2007-05-31 | Mcgill University | Intraocular pressure-regulated early genes and uses thereof |
| EP1921087A1 (en) | 2006-11-10 | 2008-05-14 | Primm S.R.L. | Process for the preparation of cyclic peptides |
-
2006
- 2006-11-22 AU AU2006318550A patent/AU2006318550A1/en not_active Abandoned
- 2006-11-22 CN CN2006800515976A patent/CN101360999B/zh not_active Expired - Fee Related
- 2006-11-22 EP EP06844496.7A patent/EP1957986B1/en active Active
- 2006-11-22 CA CA2630668A patent/CA2630668C/en active Active
- 2006-11-22 WO PCT/US2006/045169 patent/WO2007062101A2/en not_active Ceased
- 2006-11-22 JP JP2008542430A patent/JP5249774B2/ja not_active Expired - Fee Related
-
2008
- 2008-05-22 US US12/154,396 patent/US8563520B2/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2237430Y (zh) * | 1995-07-20 | 1996-10-16 | 北京市橡胶制品设计研究院 | 青光眼房水引流盘 |
| WO2004069258A2 (de) * | 2003-02-07 | 2004-08-19 | Florian Lang | Verwendung der sgk-genfamilie zur diagnose und zur therapie von katarakt und glaukom |
| WO2005060542A2 (en) * | 2003-12-17 | 2005-07-07 | Alcon, Inc. | Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
Non-Patent Citations (1)
| Title |
|---|
| Marcelo Rudzinski et al..Changes in Retinal Expression of Neurotrophins and Neurotrophin Receptors Induced by Ocular Hypertension.《Journal of Neurobioligy》.2004,第58卷(第3期),第350页左栏最后一段. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2630668A1 (en) | 2007-05-31 |
| JP5249774B2 (ja) | 2013-07-31 |
| US8563520B2 (en) | 2013-10-22 |
| WO2007062101A2 (en) | 2007-05-31 |
| EP1957986B1 (en) | 2017-05-24 |
| EP1957986A2 (en) | 2008-08-20 |
| WO2007062101A3 (en) | 2008-03-06 |
| AU2006318550A1 (en) | 2007-05-31 |
| CA2630668C (en) | 2016-07-12 |
| CN101360999A (zh) | 2009-02-04 |
| US20080305103A1 (en) | 2008-12-11 |
| JP2009519232A (ja) | 2009-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8563520B2 (en) | Treatment of ocular disease with inhibitors of alpha2 macroglobulin protein | |
| Besirli et al. | Autophagy activation in the injured photoreceptor inhibits fas-mediated apoptosis | |
| Chinskey et al. | Control of photoreceptor autophagy after retinal detachment: the switch from survival to death | |
| Xie et al. | Intranasal administration of recombinant Netrin-1 attenuates neuronal apoptosis by activating DCC/APPL-1/AKT signaling pathway after subarachnoid hemorrhage in rats | |
| Kapell et al. | Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination | |
| US20200206167A1 (en) | Inhibitor of trpm-4 ion channel for treating or preventing neurodegeneration | |
| Li et al. | The P300/XBP1s/Herpud1 axis promotes macrophage M2 polarization and the development of choroidal neovascularization | |
| US20210113687A1 (en) | Methods for treating inflammation | |
| US20080260644A1 (en) | Chloride transport upregulation for the treatment of traumatic brain injury | |
| US20080242608A1 (en) | Methods and compositions for treating and preventing neurologic disorders | |
| JP2016523969A (ja) | エンドセリンb受容体アゴニストを用いた、神経精神疾患を治療するための組成物及び方法 | |
| WO2014165181A1 (en) | Compositions for treatment of retinal detachment | |
| Bessero et al. | Role of the c‐Jun N‐terminal kinase pathway in retinal excitotoxicity, and neuroprotection by its inhibition | |
| US20070173453A1 (en) | Methods of preventing or treating brain ischemia or brain injury | |
| Liu et al. | Opticin Ameliorates Hypoxia-Induced Retinal Angiogenesis by Suppression of Integrin α2-I Domain–Collagen Complex Formation and RhoA/ROCK1 Signaling | |
| US20170266146A1 (en) | Compositions and methods for treatment of retinal degenerative diseases | |
| Cooper et al. | The relationship between neurotrophic factors and CaMKII in the death and survival of retinal ganglion cells | |
| AU2012202220A1 (en) | Intraocular pressure-regulated early genes and uses thereof | |
| US10369191B2 (en) | Modulation of epigenetic stress response | |
| US20120232121A1 (en) | Use of sarcoplasmic ca2+-atpase type 2 protein for diagnosing and treating learning or mental disorders | |
| US20070087966A1 (en) | Prolactin and chronic and acute pain disorders | |
| EP3003341B1 (en) | Compositions for use in methods for treatment of retinal degenerative diseases | |
| Tapanes | Glial Derived D-serine Mediates Synaptic Damage in the Traumatically Injured Brain | |
| Klein et al. | Why Alzheimer’s is a disease of memory: Synaptic targeting by pathogenic Aβ oligomers (ADDLs) | |
| US20090048146A1 (en) | Use of agents that upregulate crystallin expression in the retina and optic nerve head |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130717 |